Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-015898

Options or other derivatives

  • Chief Legal Officer acquired 68,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Ali-Jackson Kamil Chief Legal Officer 2019-03-01 Grant or award · Restricted stock units +68,700 68,700 D
Loading xslF345X03/doc4.xml…